Biocomposites Acquires Artoss and NanoBone Technology

Artoss NanoBone Technology

Following the acquisition of Artoss, Biocomposites has added proprietary NanoBone technology to its product portfolio, a combination of nanocrystalline hydroxyapatite and silica gel - to provide optimal bone formation with easy handling.
Biocomposites acquired Artoss, a specialist manufacturer of bone graft substitutes for use in orthopedics,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us